A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method

Clinica Chimica Acta

Volumn 333, Issue 1-2, 2003, Pages 59-67

  Kishimoto, Tatsuya ^a   Matsuoka, Takeshi ^b   Imamura, Shigeyuki ^b   Mizuno, Koji ^a  

^a Nesco Company   (Japan)

^b Diagnostics R and D Department   (Japan)

Author keywords

Diagnosis; Enzymatic assay; Enzymatic cycling; LPA; Lysophosphatidic acid; Lysophospholipid

Indexed keywords

EDETIC ACID; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCEROL 3 PHOSPHATE OXIDASE; HYDROGEN PEROXIDE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; OXIDOREDUCTASE; PHOSPHATIDIC ACID; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; CHEMICAL ANALYSIS; COLORIMETRY; CONCENTRATION (PARAMETERS); ENZYMATIC ASSAY; FEMALE; GENDER; HUMAN; HYDROLYSIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SERUM;

EID: 0037505638     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00165-7     Document Type: Article

References (40)

1. van Corven E.J., Groenink A., Jalink K., Eichholtz T., Moolenaar W.H. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 59:1989;45-54.
2. van Corven E.J., van Rijswijk A., Jalink K., van der Bend R.L., van Blitterswijk W.J., Moolenaar W.M. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin. Biochem. J. 281:1992;163-169.
3. Tokumura A., Iimori M., Nishioka Y., Kitahara M., Sakashita M., Tanaka S. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Physiol. 267:1994;C204-C210.
4. Piazza G.A., Ritter J.L., Baracka C.A. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp. Cell Res. 216:1995;51-64.
5. Gerrard J.M., Kindom S.E., Peterson D.A., Peller J., Krantz K.E., White J.G. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux. Am. J. Pathol. 96:1979;423-438.
6. Tokumura A., Fukuzawa K., Yamada S., Tsukatani H. Stimulatory effect of lysophosphatidic acids on uterine smooth muscles of non-pregnant rats. Arch. Int. Pharmacodyn. Ther. 245:1980;74-83.
7. Imamura F., Horai T., Mukai M., Shinkai K., Sawada M., Akedo H. Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun. 193:1993;497-503.
8. Nishikawa T., Tomori Y., Yamashita S., Shimizu S. Inhibition of Na+, K+-ATPase activity by phospholipase A2 and several lysophospholipids: possible role of phospholipase A2 in noradrenaline release from cerebral cortical synaptosomes. J. Pharm. Pharmacol. 41:1989;450-458.
9. Shiono S., Kawamoto K., Yoshida N., Kondo T., Inagami T. Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors. Biochem. Biophys. Res. Commun. 193:1993;667-673.
10. Jalink K., Moolenaar W.H., van Duijn B. Lysophosphatidic acid is a chemoattractant for Dictyostelium discoideum amoebae. Proc. Natl. Acad. Sci. U. S. A. 90:1993;1857-1861.
11. Ridley A.J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 70:1992;389-399.
12. Ridley A.J., Hall A. Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase. EMBO J. 13:1994;2600-2610.
13. Hayashi K., Takahashi M., Nishida W., Yoshida K., Ohkawa Y., Kitabatake A.et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 89:2001;251-258.
14. Zhou D., Luini W., Bernasconi S., Diomede L., Salmona M., Mantovani A.et al. Phosphatidic acid and lysophosphatidic acid induce haptotactic migration of human monocytes. J. Biol. Chem. 270:1995;25549-25556.
15. Fishman D.A., Liu Y., Ellerbroek S.M., Stack M.S. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells. Cancer Res. 61:2001;3194-3199.
16. McIntyre T.M., Pontsler A.V., Silva A.R., St. Hilaire A., Xu Y., Hinshaw J.C.et al. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist. Proc. Natl. Acad. Sci. U. S. A. 100:2003;131-136.
17. Hecht J.H., Weiner J.A., Post S.R., Chun J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135:1996;1071-1083.
18. An S., Bleu T., Hallmark O.G., Goetzl E.J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273:1998;7906-7910.
19. Bandoh K., Aoki J., Hosono H., Kobayashi S., Kobayashi T., Murakami-murofushi K.et al. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J. Biol. Chem. 274:1999;27776-27785.
20. Eichholtz T., Jalink K., Fahrenfort I., Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291:1993;677-680.
21. Xu Y., Shen Z., Wiper D.M., Wu M., Morton R.E., Elson P.et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 280:1998;719-723.
22. Xu Y., Gaudette D.C., Boynton J.D., Frankel A., Fang X.J., Sharma A.et al. Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients. Clin. Cancer Res. 1:1995;1223-1232.
23. Liliom K., Guan Z., Tseng J.L., Desiderio D.M., Tigyi G., Watsky M.A. Growth factor-like phospholipids generated after corneal injury. Am. J. Physiol. 274:1998;C1065-C1074.
24. Tokumura A., Miyake M., Nishioka Y., Yamano S., Aono T., Fukuzawa K. Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of in vitro fertilization patients. Biol. Reprod. 61:1999;195-199.
25. Sugiura T., Nakane S., Kishimoto S., Waku K., Yoshioka Y., Tokumura A. Lysophosphatidic acid, a growth factor-like lipid, in the saliva. J. Lipid Res. 43:2002;2049-2055.
26. Sasagawa T., Okita M., Murakami J., Kato T., Watanabe A. Abnormal serum lysophospholipids in multiple myeloma patients. Lipids. 34:1999;17-21.
27. Tokumura A., Harada K., Fukuzawa K., Tsukatani H. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim. Biophys. Acta. 875:1986;31-38.
28. Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K.et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158:2002;227-233.
29. Tokumura A., Majima E., Kariya Y., Tominaga K., Kogure K., Yasuda K.et al. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277:2002;39436-39442.
30. Stracke M.L., Krutzsch H.C., Unsworth E.J., Arestad A., Cioce V., Schiffmann E.et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J. Biol. Chem. 267:1992;2524-2529.
31. Saulnier-Blache J.S., Girard A., Simon M.F., Lafontan M., Valet P. A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J. Lipid Res. 41:2000;1947-1951.
32. Baker D.L., Desiderio D.M., Miller D.D., Tolley B., Tigyi G.J. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal. Biochem. 292:2001;287-295.
33. Aoki J., Taira A., Takanezawa Y., Kishi Y., Hama K., Kishimoto T.et al. Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J. Biol. Chem. 277:2002;48737-48744.
34. Ueda S., Imamura S., Misaki H. A high sensitive determination of phosphatidylglycerol in amniotic fluid by enzymatic cycling assay. Clin. Chem. 32:1986;1096.
35. Valero E., Garcia-Carmona F. Optimizing enzymatic cycling assays: spectrophotometric determination of low levels of pyruvate and L-lactate. Anal. Biochem. 239:1996;47-52.
36. Valero E., Garcia-Carmona F. A continuous spectrophotometric method based on enzymatic cycling for determining L-glutamate. Anal. Biochem. 259:1998;265-271.
37. Kishimoto T., Soda Y., Matsuyama Y., Mizuno K. An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin. Biochem. 35:2002;411-416.
38. Tigyi G., Miledi R. Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 phenochromocytoma cells. J. Biol. Chem. 267:1992;21360-21367.
39. Tokumura A., Miyake M., Yoshimoto O., Shimizu M., Fukuzawa K. Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma. Lipids. 33:1998;1009-1015.
40. Baker D.L., Morrison P., Miller B., Riely C.A., Tolley B., Westermann A.M.et al. Plasma lysophosphatidic acid concentration and ovarian cancer. JAMA. 287:2002;3081-3082.